Prostate MRI in the United Kingdom: a survey of current practice by the British Society of Urogenital Radiology
British Journal of Radiology · 2025
DOI: 10.1093/bjr/tqaf312 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Radiology, 2025. Verfasst von Samuel J Withey und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, United Kingdom. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Prostatic Neoplasms, Practice Patterns, Physicians'. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To characterize contemporary UK practice in prostate MRI reporting and pathways, and identify priorities for standardization.
Methods
Between February and April 2025, a questionnaire was distributed by the British Society of Urogenital Radiology to UK-based consultant radiologists who report prostate MRI. It contained 34 questions, covering 6 domains: demographics; MRI protocols; biopsy; reporting preferences; imaging pathways; and attitudes towards accreditation.
Results
Seventy-seven radiologists representing 52 NHS Trusts across all nations of the UK responded. Key findings include variable patient preparation for MRI including anti-spasmodic medication (69.2% administering) and instruction related to bowel preparation (13.5%). Trusts (100) were performing MRI prior to biopsy for suspected cancer; 73.1% using multiparametric MRI. When reporting prostate MRI for suspected cancer, 28.6% document only a PI-RADS score, 27.3% only a Likert score, with 44.1% stating both. The PI-QUAL score is moderately well known (71.4% of respondents) but not in routine use (7.8%). Transperineal prostate biopsy was performed at 88.5% of Trusts, with biopsy more likely to be performed by urologists (98.1% of Trusts) or urology nurses (36.5%) than radiologists (26.9%). Patients with high- or very high-risk prostate cancer undergo variable staging pathways, with university teaching hospitals more likely to offer PSMA PET/CT than other settings (33.3% vs 12.0%, P = .023).
Conclusions
This survey shows the current state of UK prostate MRI practice, including universal pre-biopsy MRI. It identifies areas for standardization, including MRI protocols, scoring systems, and national staging guidelines. Advances in knowledge Provides an up-to-date snapshot on prostate MRI within the UK.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, United Kingdom.
- British Society of Urogenital Radiology, Devon, United Kingdom.
- Centre for Medical Imaging, University College London, London WC1E 6AG, United Kingdom.
- Department of Radiology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, United Kingdom.
ORCID-Profile: Samuel J Withey, Tristan Barrett
Zitieren
APA
Withey, S. J., Caglic, I., & Barrett, T. (2025). Prostate MRI in the United Kingdom: a survey of current practice by the British Society of Urogenital Radiology. British Journal of Radiology. https://doi.org/10.1093/bjr/tqaf312
Vancouver
Withey SJ, Caglic I, Barrett T. Prostate MRI in the United Kingdom: a survey of current practice by the British Society of Urogenital Radiology. British Journal of Radiology. 2025. doi:10.1093/bjr/tqaf312
BibTeX
@article{Withey2025,
author = {Withey, Samuel J and Caglic, Iztok and Barrett, Tristan},
title = {Prostate MRI in the United Kingdom: a survey of current practice by the British Society of Urogenital Radiology},
journal = {British Journal of Radiology},
year = {2025},
doi = {10.1093/bjr/tqaf312}
}
EUVIMED